Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, Egawa H, Fujita S, Hayashi M, Tanaka K
Department of Transplantation and Immunology, Kyoto University Faculty of Medicine, Japan.
Transplantation. 1999 Jan 27;67(2):321-7. doi: 10.1097/00007890-199901270-00024.
Although living donor liver transplantation for small pediatric patients is increasingly accepted, its expansion to older/larger patients is still in question because of the lack of sufficient information on the impact of graft size mismatching.
A total of 276 cases of living donor liver transplantation, excluding ABO-incompatible, auxiliary, or secondary transplants, were reviewed from graft size matching. Forty-three cases were highly urgent cases receiving intensive care preoperatively. Cases were categorized into five groups by graft-to-recipient weight ratio (GRWR): extra-small-for-size (XS; GRWR<0.8%, 17 elective and 4 urgent cases), small (S; 0.8< or =GRWR< 1.0%, 21 and 7), medium (M; 1.0< or =GRWR<3.0%, 119 and 19), large (L; 3.0< or =GRWR<5.0%, 67 and 10), and extra-large (XL; GRWR> or =5.0%, 9 and 3).
Smaller-for-size grafts were associated not only with larger and older recipients, but also with rather older donors. Posttransplant bilirubin clearance was delayed and aspartate aminotransferase corrected by relative graft size was higher in XS and S. Posttransplant hemorrhage and intestinal perforation were more frequent in XS and S, and vascular complications and acute rejection were more frequent in larger-for-size grafts. Consequently, graft survival in XS (cumulative 58% and actuarial 42% at 1 year) and S (76% and 74%) was significantly lower compared with that in M (93% and 92%) in elective cases. Graft survival in L (83% and 82%) and XL (75% and 71%) did not reach statistical significance.
The use of small-for-size grafts (less than 1% of recipient body weight) leads to lower graft survival, probably through enhanced parenchymal cell injury and reduced metabolic and synthetic capacity. Although large-for-size grafts are associated with some anatomical and immunological disadvantages, the negative impact is less pronounced.
尽管活体供肝移植在小儿患者中越来越被接受,但由于缺乏关于移植物大小不匹配影响的足够信息,其在年龄较大/体型较大患者中的应用仍存在疑问。
从移植物大小匹配方面回顾了276例活体供肝移植病例,排除ABO血型不相容、辅助或二次移植病例。43例为术前接受重症监护的高度紧急病例。根据移植物与受者体重比(GRWR)将病例分为五组:超小体积(XS;GRWR<0.8%,17例择期和4例紧急病例)、小体积(S;0.8≤GRWR<1.0%,21例和7例)、中等体积(M;1.0≤GRWR<3.0%,119例和19例)、大体积(L;3.0≤GRWR<5.0%,67例和10例)和超大体积(XL;GRWR≥5.0%,9例和3例)。
体积较小的移植物不仅与年龄较大、体型较大的受者相关,也与年龄较大的供者相关。XS组和S组移植后胆红素清除延迟,相对移植物大小校正后的天冬氨酸转氨酶较高。XS组和S组移植后出血和肠穿孔更常见,而体积较大的移植物血管并发症和急性排斥反应更常见。因此,在择期病例中,XS组(1年累计生存率58%,精算生存率42%)和S组(76%和74%)的移植物生存率显著低于M组(93%和92%)。L组(83%和82%)和XL组(75%和71%)的移植物生存率未达到统计学显著性差异。
使用小体积移植物(小于受者体重的1%)可能通过增强实质细胞损伤以及降低代谢和合成能力导致移植物生存率降低。尽管大体积移植物存在一些解剖学和免疫学方面的劣势,但其负面影响不太明显。